Equity (Tables)

12 Months Ended

Dec. 31, 2022

Stockholders' Equity Note [Abstract]

Schedule of stock option activity

	Number of Options (in Shares)			Weighted Average Exercise Price
Outstanding, January 1, 2022		1,656,000		$	2.00
Granted		-		$	-
Exercised		-			-
Forfeited or cancelled		(48,500	)		-
Outstanding, December 31, 2022		1,607,500		$	2.00
Exercisable, December 31, 2022		1,607,500		$	2.00

Schedule of table represents the activity

	Number of Warrants (in Shares)			Weighted Average Exercise Price
Outstanding, January 1, 2022		5,926,763		$	*
Granted		1,004,576,431			.001
Exercised		(418,931	)		-
Outstanding, December 31, 2022		1,010,084,263		$	-

	Prefunded Warrants
Outstanding, January 1, 2022		15,361,622
New issuances		-
Exercised		12,361,622
Outstanding, December 31, 2022		3,000,000

	Number of Restricted Stock Shares		Weighted Average Grant Date Fair Value
Outstanding, January 1, 2022		1,100,000	$	0.48
Granted		-		-
Vested		1,100,000		0.40
Unvested, December 31, 2022		-	$	-

Schedule of share derivative liabilities

	December 31, 2022
Warrants	$	272
Stock options		1
Total share derivative liability	$	273

Schedule of reverse stock split balance sheet

			Proforma
	As Stated		Effect
Balance Sheet
Common stock:
Shares Issued:
12/31/2022		2,484,501,880		2,484,502
12/31/2021		145,713,591		145,714
Shares Outstanding:
12/31/2022		2,484,426,501		2,484,427
12/31/2021		145,638,212		145,638
Treasury Stock:		75,379		75

Schedule of reverse stock split EPS

		Year Ended December 31,
EPS		2022			2021
Weighted Average Shares
Outstanding – basic and diluted	As stated		843,858,474			139,061,084
	Proforma		843,858			139,061
Net income (loss) per share:
Continuing operations	As stated		(0.010	)		(0.38	)
	Proforma		(10.00	)		(38.00	)
Discontinued Operations	As stated		(0.004	)		0.02
	Proforma		(4.00	)		20.00